ClinicalTrials.Veeva

Menu

Stem Cells and Resynchronization Cardiac (RCT and SCT)

I

Instituto de Molestias Cardiovasculares

Status and phase

Unknown
Phase 1

Conditions

Heart Failure

Treatments

Procedure: Pacing and Stem Cells Implantation
Procedure: Pacing and Stem Cells Implantations.

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT00800657
HFRCTC1

Details and patient eligibility

About

Same patients with dilated myocardiopathies with large areas of fibrosis has not been as successful after Cardiac Resynchronization Therapy, for Heart Failure patients in functional class III or IV. Therefore the investigators have decided to associate the Stem-Cell implant with Cardiac Resynchronization Therapy in these patients.

Full description

About 120cc of blood are collected from the iliac bone marrow under epidural anesthesia.In the cell therapy lab this blood is harvested and mononuclear cells are separated.This procedure takes roughly 4 hours.After dilution the mononuclear cells are injected into the cardiac muscles with fibroses area through 20 shots.This procedure is indicated for patients with cardiac ischemia and left ventricular dysfunction(desynchrony), on whom all the others known therapies have failed.

Enrollment

30 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

  • Dilated Cardiomyopathy
  • Heart Failure
  • Optimized Therapeutics
  • Ventricular Desynchrony
  • Functional Class III or IV
  • Ejection Fraction(Echo/ Sympson) < 35%

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

Single Blind

Trial contacts and locations

1

Loading...

Central trial contact

Ana Carolina de Abreu, MD; Oswaldo Tadeu Greco, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems